Commentary: Could the Lack of an Efficient and Affordable Diagnostic Pathway Limit Market Access for New Alzheimer’s Treatments?
Rick Lifsitz and Larry Blandford address market access for novel Alzheimer’s treatments in a new commentary for Journal of Clinical Pathways
Real World Superiority Data May Not Be Enough To Boost GSK’s Breo In COPD – The Pink Sheet
Precision for Value’s Dan Renick offers his perspective on GSK’s Breo in The Pink Sheet.
GSK Leads Way With Real World Data, But Others Follow – The Pink Sheet
Dan Renick comments on the importance of value demonstration for respiratory disease treatments in The Pink Sheet.
What’s the Deal – The Wall Street Journal
Pharma Industry Firm Moves for More Space
Precision for Value, a company that helps bring pharmaceutical products to market, has found a larger home at One Grand Central Place.
ACT Oncology Wins the PACT 2016 Enterprise Award for Emerging Healthcare Companies
Flemington, N.J., May 19, 2016 – ACT Oncology announced today it has been awarded the Philadelphia Alliance for Capital and Technologies (PACT) 2016 Enterprise Award for Emerging Healthcare companies. The Enterprise Awards, held annually, are the region’s most prestigious business honors for innovative life sciences and technology companies, leaders, and entrepreneurs.